Announcing a $200M VHH discovery collaboration with Abkyu to accelerate next-gen biologics.
Jeevan Therapeutics has entered into a strategic discovery partnership with Abkyu to accelerate the development of next-generation biologics aimed at transforming patient care.
Newsletters
Breaking New Ground: Jeevan's Recent Wins and What's Ahead
In the first part of 2025 we have achieved several key milestones positioning Jeevan for an exciting rest of year, looking into 2026!
Advancing Discovery at Jeevan Therapeutics
Since our last update in September 2025, we have made meaningful discovery-stage progress — sharpening our strategic focus, advancing our lead program, and strengthening key scientific collaborations — positioning Jeevan for an important year ahead.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.